Bajaj Healthcare First in India to Secure SEC Nod for Cenobamate Tablets

Bajaj Healthcare became the first Indian company to receive SEC recommendation to manufacture and market Cenobamate tablets for partial-onset seizures. This milestone advances its CNS portfolio and positions it for final regulatory approval.